Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6301 AL 6315

From alpha to omega with Abeta: targeting the multiple molecular appearances of the pathogenic peptide in Alzheimer's disease

De Kimpe L, Scheper W.

Curr Med Chem. 2010;17(3):198-212. doi: 10.2174/092986710790149765.

Methylphenidate for apathy and functional status in dementia of the Alzheimer type

Padala PR, Burke WJ, Shostrom VK, Bhatia SC, Wengel SP, Potter JF, Petty F.

Am J Geriatr Psychiatry. 2010 Apr;18(4):371-4. doi: 10.1097/JGP.0b013e3181cabcf6.

Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants

Cornelli U.

Neurodegener Dis. 2010;7(1-3):193-202. doi: 10.1159/000295663. Epub 2010 Mar 12.

Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE)

Gauthier S, Juby A, Dalziel W, Réhel B, Schecter R; EXPLORE investigators.

Curr Med Res Opin. 2010 May;26(5):1149-60. doi: 10.1185/03007991003688888.

Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches

Galimberti D, Scarpini E.

Curr Aging Sci. 2010 Feb;3(1):46-56. doi: 10.2174/1874609811003010046.

Early Alzheimer's trials: new developments

Vellas B, Aisen PS.

J Nutr Health Aging. 2010 Apr;14(4):293. doi: 10.1007/s12603-010-0064-3.

Pre-dementia Alzheimer's trials: overview

Aisen PS.

J Nutr Health Aging. 2010 Apr;14(4):294. doi: 10.1007/s12603-010-0065-2.

Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease

Holscher C.

Recent Pat CNS Drug Discov. 2010 Jun;5(2):109-17. doi: 10.2174/157488910791213130.

Medication in elderly people: its influence on salivary pattern, signs and symptoms of dry mouth

Leal SC, Bittar J, Portugal A, Falcão DP, Faber J, Zanotta P.

Gerodontology. 2010 Jun;27(2):129-33. doi: 10.1111/j.1741-2358.2009.00293.x. Epub 2010 Mar 11.

Vaccines against non-communicable diseases

Röhn TA, Bachmann MF.

Curr Opin Immunol. 2010 Jun;22(3):391-6. doi: 10.1016/j.coi.2010.02.009. Epub 2010 Mar 24.

Treatment of apathy in Alzheimer's disease with transdermal rivastigmine: report of three cases

Granero AL, Lucchetti G.

Braz J Psychiatry. 2010 Mar;32(1):94-5. doi: 10.1590/s1516-44462010000100019.

Tacrine derivatives and Alzheimer's disease

Tumiatti V, Minarini A, Bolognesi ML, Milelli A, Rosini M, Melchiorre C.

Curr Med Chem. 2010;17(17):1825-38. doi: 10.2174/092986710791111206.

[Influence of acupuncture on isoprostane in patients with Alzheimer's disease]

Zhu H, Dong KL, Wu Y, Zhang T, Li RM, Dai SS, Wang HL.

Zhongguo Zhen Jiu. 2010 Jan;30(1):18-21.

[The role of cyclooxygenases in neurotoxicity of amyloid beta peptides in Alzheimer's disease]

Cakała M, Strosznajder JB.

Neurol Neurochir Pol. 2010 Jan-Feb;44(1):65-79. doi: 10.1016/s0028-3843(14)60407-2.

Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study

Gardette V, Andrieu S, Lapeyre-Mestre M, Coley N, Cantet C, Ousset PJ, Grand A, Monstastruc JL, Vellas B.

CNS Drugs. 2010 May;24(5):431-42. doi: 10.2165/11318010-000000000-00000.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias